Welch & Forbes LLC Merck & Co., Inc. Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Welch & Forbes LLC holds 367,565 shares of MRK stock, worth $36.5 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

367,565

Previous 372,011 1.2%

Holding current value

$36.5 Million

Previous $46.1 Million 9.37%

% of portfolio

0.54%

Previous 0.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$111.15 - $128.97 $494,172 - $573,400	-4,446 Reduced 1.2%	367,565 $41.7 Million
Q2 2024 Aug 01, 2024	SELL	$123.8 - $132.96 $200,679 - $215,528	-1,621 Reduced 0.43%	372,011 $46.1 Million
Q1 2024 May 02, 2024	SELL	$113.24 - $131.95 $816,913 - $951,887	-7,214 Reduced 1.89%	373,632 $49.3 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $1.24 Million - $1.35 Million	-12,375 Reduced 3.15%	380,846 $41.5 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $479,026 - $531,977	-4,653 Reduced 1.17%	393,221 $40.5 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $304,542 - $331,937	-2,804 Reduced 0.7%	397,874 $45.9 Million
Q1 2023 Apr 14, 2023	SELL	$102.94 - $114.86 $418,348 - $466,791	-4,064 Reduced 1.0%	400,678 $42.6 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $32,964 - $42,265	-377 Reduced 0.09%	404,742 $44.9 Million
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $240,741 - $270,446	2,848 Added 0.71%	405,119 $34.9 Million
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $51,179 - $58,014	-613 Reduced 0.15%	402,271 $36.7 Million
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $105,854 - $118,656	1,440 Added 0.36%	402,884 $33.1 Million
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $389,300 - $487,648	-5,386 Reduced 1.32%	401,444 $30.8 Million
Q3 2021 Oct 13, 2021	SELL	$71.68 - $78.83 $723,322 - $795,473	-10,091 Reduced 2.42%	406,830 $30.6 Million
Q2 2021 Jul 22, 2021	SELL	$70.31 - $77.77 $752,457 - $832,294	-10,702 Reduced 2.5%	416,921 $32.4 Million
Q1 2021 Apr 14, 2021	SELL	$68.86 - $81.11 $236,534 - $278,612	-3,435 Reduced 0.8%	427,623 $33 Million
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $539,710 - $598,968	-7,520 Reduced 1.71%	431,058 $35.3 Million
Q3 2020 Oct 23, 2020	SELL	$73.18 - $82.95 $241,933 - $274,232	-3,306 Reduced 0.75%	438,578 $36.4 Million
Q2 2020 Jul 15, 2020	SELL	$70.42 - $80.13 $865,954 - $985,358	-12,297 Reduced 2.71%	441,884 $34.2 Million
Q1 2020 Apr 17, 2020	BUY	$63.36 - $87.82 $115,188 - $159,656	1,818 Added 0.4%	454,181 $34.9 Million
Q4 2019 Jan 17, 2020	BUY	$77.58 - $87.54 $115,516 - $130,347	1,489 Added 0.33%	452,363 $41.1 Million
Q3 2019 Oct 11, 2019	SELL	$76.08 - $82.93 $204,807 - $223,247	-2,692 Reduced 0.59%	450,874 $38 Million
Q2 2019 Jul 12, 2019	SELL	$69.84 - $81.59 $432,309 - $505,042	-6,190 Reduced 1.35%	453,566 $38 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $1.34 Million - $1.53 Million	-19,275 Reduced 4.02%	459,756 $38.2 Million
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $779,878 - $905,037	-11,954 Reduced 2.43%	479,031 $36.6 Million
Q3 2018 Oct 17, 2018	SELL	$57.69 - $67.84 $388,080 - $456,359	-6,727 Reduced 1.35%	490,985 $34.8 Million
Q2 2018 Jul 16, 2018	SELL	$50.83 - $59.72 $551,098 - $647,484	-10,842 Reduced 2.13%	497,712 $30.2 Million
Q1 2018 Apr 12, 2018	BUY	$50.96 - $59.23 $86,733 - $100,809	1,702 Added 0.34%	508,554 $27.7 Million
Q4 2017 Jan 26, 2018	SELL	$51.62 - $61.64 $1.5 Million - $1.79 Million	-29,081 Reduced 5.43%	506,852 $28.5 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $31.4 Million - $33.8 Million	535,933	535,933 $34.3 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account